Pancreatic Cancer Therapy Market Size, Growth, Analysis by Recent Trends, Development and Forecast To 2025

 Rise in number of patients suffering with pancreatic cancer is driving the market for pancreatic cancer therapy over the forecast period


According to The Insight Partners market research study titled ‘Pancreatic Cancer Therapy Market - Global Analysis and Forecasts By Type, Therapy, the global pancreatic cancer therapy market is expected to reach US$ 4,056.4 Mn in 2025 from US$ 2,011.2 Mn in 2017. The market is estimated to grow with a CAGR of 8.1% from 2018-2025. The report highlights the trends prevalent in the global pancreatic cancer therapy market and the factors driving the market along with those that act as deterrents to its growth.

Global pancreatic cancer therapy market, based on the type was segmented into endocrine pancreatic cancer and exocrine pancreatic cancer. In 2017, the exocrine pancreatic cancer segment held the largest share of the market, by type. The exocrine pancreatic cancer segment is expected to grow at the fastest rate during the coming years as this cancer is majorly occurring cancer type among the two and thus is expected to have massive patient pool over the forecast years.

Explore Premium Report on Pancreatic Cancer Therapy Market at: https://www.theinsightpartners.com/sample/TIPMD00002009/

The market for pancreatic cancer therapy is expected to grow due to rise in number of patients suffering with pancreatic cancer, increasing healthcare expenditures for pancreatic drugs, and increase in number of therapies launched in the market are boosting the market over the years. In addition, development of efficient therapy for pancreatic cancer treatment are likely to have a positive impact on the growth of the pancreatic cancer therapy market in the coming years.

The major players operating in the pancreatic cancer therapy market include Eli Lilly and Company, F. Hoffmann-La Roche AG, Celgene Corporation, Amgen Inc., Novartis AG, Pharmacyte Biotech Inc., Clovis Oncology, Teva Pharmaceutical Industries Ltd., Pfizer Inc., Merck & Co., Inc. among others. For instance, in May 2018, Eli Lilly and Company acquired AMRO BioSciences. AMRO BioSciences is engaged into number of drugs for cancer. The clinical trial explores a drug (pegilodecakin) which is ongoing for the pancreatic cancer. The drug is into phase III of the clinical trials. The developments performed by the companies are helping the market to grow in the coming years.

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

Contact Us:

If you have any queries about this report or if you would like further information, please contact us:

Contact Person: Sameer Joshi

E-mail: sales@theinsightpartners.com

Phone: +1-646-491-9876

Comments

Post a Comment

Popular posts from this blog

Liquid Biopsy Market Size, Share, Analysis, Trends and Forecast by 2027

  According to our new research study on “ Liquid Biopsy Market Forecast to 2027 – COVID-19 Impact and Global Analysis – by Product & Services, Sample, Circulating Biomarker, Application, and End User,” the market is expected to reach US$ 8,123.85 million by 2027 from US$ 3,861.49 million in 2019. It is estimated that the market CAGR accounts for 9.9% during 2020–2027. The global liquid biopsy market report highlights trends prevailing in the market and factors driving its growth. The liquid biopsy market is attributed to grow due to increasing prevalence of cancer, government and global health organizations initiatives. However, the low sensitivity of liquid biopsy is expected to restraint the global liquid biopsy market growth.   The  global  liquid biopsy market forecast is studied from 2019 to 2027. In 2019, North America accounted for the largest  market share . The market growth in the region is attributed to the increasing number of orthopedic ...
Read more

Frozen Food Market 2022 Industry Size, Share, Business Strategies, Emerging Technology, Product Portfolio, Countries Data and Demand Synopsis

  According to the new research study titled " Frozen Food Market to Forecast 2028 – COVID-19 Impact and Global Analysis – by Type, Distribution Channel, and Geography," the market is expected to grow from US$ 251,155.35 million in 2021 to US$ 373,767.59 million by 2028; it is expected to grow at a CAGR of 5.9% from 2022 to 2028. Over the past few years, the surge in the consumption of high-quality convenience food has been one of the biggest trends in the food industry. Convenience food, such as frozen snacks, frozen meals, cold cuts, and ready-to-eat products, allows consumers to save time and efforts associated with ingredient shopping, meal preparation and cooking, consumption, and post-meal activities. Due to hectic work schedules, millennials prefer to be efficient with their time rather than spending it on tedious tasks. Thus, they are more likely to spend their money on convenience food. Moreover, the growing number of one or two-person families can be related to t...
Read more

Orthopedic Braces and Supports Market Size 2020, Statistics, Trends, Regional Analysis by Key Players

  According to The Insight Partners market research study titled ‘ Orthopedic Braces and Supports Market to 2025 – Global Analysis and Forecasts by Product and Application. The global orthopedic braces and supports market is expected to reach US$ 5,429.3Mn in 2025 from US$ 3,631.2Mn in 2017. The market is estimated to grow with a CAGR of 5.3% from 2018-2025. The report highlights the trends prevalent in the global orthopedic braces and supports market and the factors driving the market. Global orthopedic braces and supports market, based on product was segmented into knee, back & hip, shoulder, elbow, foot and ankle and spine. In 2017, knee segment held the largest share of the market, by product. Whereas, the shoulder segment is reported to be the fastest growing of the market owing to the advantages provided by the braces such as providing support for the shoulder and the joint pains. Also the shoulder brace braces provides correct posture habits, keeps shoulder elevated t...
Read more